Clinical Trials Directory

Trials / Completed

CompletedNCT04683614

Intraoperative Norepinephrine Versus Fresh Frozen Plasma in Patients Undergoing HIPEC to Reduce Renal Insult

Intraoperative Norepinephrine Versus Fresh Frozen Plasma in Patients Undergoing HIPEC to

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
National Cancer Institute, Egypt · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

comparing the effect of low dose norepinephrine infusion versus fresh frozen plasma in patients undergoing HIPEC to reduce renal insult

Detailed description

To compare the efficacy of maintaining intraoperative hemodynamic stability through infusing low dose norepinephrine versus fresh frozen plasma in patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy in cancer patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy

Conditions

Interventions

TypeNameDescription
DRUGNorepinephrine5 mic/kg/hr norepinephrine
BIOLOGICALFresh frozen plasmaearly administration of fresh frozen plasma

Timeline

Start date
2020-10-20
Primary completion
2022-05-20
Completion
2022-05-28
First posted
2020-12-24
Last updated
2022-06-21

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04683614. Inclusion in this directory is not an endorsement.

Intraoperative Norepinephrine Versus Fresh Frozen Plasma in Patients Undergoing HIPEC to Reduce Renal Insult (NCT04683614) · Clinical Trials Directory